Pharmaceutical Contract Manufacturing and Contract Industry Research Report 2023

Pharmaceutical Contract Manufacturing and Contract Industry Research Report 2023


Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Highlights

The global Pharmaceutical Contract Manufacturing and Contract market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Manufacturing and Contract, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Manufacturing and Contract.
The Pharmaceutical Contract Manufacturing and Contract market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharmaceutical Contract Manufacturing and Contract market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Manufacturing and Contract companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant

Product Type Insights

Global markets are presented by Pharmaceutical Contract Manufacturing and Contract type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Pharmaceutical Contract Manufacturing and Contract are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Pharmaceutical Contract Manufacturing and Contract segment by Type

Oral
Injectable
API
Other

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pharmaceutical Contract Manufacturing and Contract market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pharmaceutical Contract Manufacturing and Contract market.
Pharmaceutical Contract Manufacturing and Contract Segment by Application

Small Medium Enterprise
Large Enterprise

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pharmaceutical Contract Manufacturing and Contract market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Manufacturing and Contract market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Manufacturing and Contract and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pharmaceutical Contract Manufacturing and Contract industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Manufacturing and Contract.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Contract Manufacturing and Contract companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Pharmaceutical Contract Manufacturing and Contract by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
2.3 Pharmaceutical Contract Manufacturing and Contract by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Small Medium Enterprise
2.3.3 Large Enterprise
2.4 Assumptions and Limitations
3 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Type
3.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Type (2018-2023)
3.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2023-2028)
4 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Application
4.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Application (2018-2023)
4.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Pharmaceutical Contract Manufacturing and Contract Market Perspective (2018-2029)
5.2 Global Pharmaceutical Contract Manufacturing and Contract Growth Trends by Region
5.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Region (2018-2023)
5.2.3 Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2024-2029)
5.3 Pharmaceutical Contract Manufacturing and Contract Market Dynamics
5.3.1 Pharmaceutical Contract Manufacturing and Contract Industry Trends
5.3.2 Pharmaceutical Contract Manufacturing and Contract Market Drivers
5.3.3 Pharmaceutical Contract Manufacturing and Contract Market Challenges
5.3.4 Pharmaceutical Contract Manufacturing and Contract Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue
6.1.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (2018-2023)
6.1.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2018-2023)
6.2 Global Pharmaceutical Contract Manufacturing and Contract Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Pharmaceutical Contract Manufacturing and Contract Head office and Area Served
6.4 Global Pharmaceutical Contract Manufacturing and Contract Players, Product Type & Application
6.5 Global Pharmaceutical Contract Manufacturing and Contract Players, Date of Enter into This Industry
6.6 Global Pharmaceutical Contract Manufacturing and Contract Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
7.2 North America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
7.4 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
8.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
8.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
9.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
9.4 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
10.2 Latin America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
10.4 Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size (2018-2029)
11.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023)
11.4 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Introduction
11.1.4 Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Introduction
11.3.4 Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Introduction
11.5.4 Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Detail
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Introduction
11.6.4 Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Detail
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Introduction
11.7.4 Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Introduction
11.8.4 AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Detail
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Introduction
11.9.4 Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Detail
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Detail
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Introduction
11.11.4 Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Detail
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Introduction
11.12.4 Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Detail
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Introduction
11.13.4 Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Detail
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Detail
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Introduction
11.15.4 Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Detail
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Introduction
11.16.4 Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Detail
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Detail
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Detail
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Detail
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Introduction
11.20.4 Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022)
11.20.5 Jubilant Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2018-2023)
Table 7. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2024-2029)
Table 9. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2018-2023)
Table 11. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Application (2024-2029)
Table 13. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2018-2023)
Table 16. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Region (2024-2029)
Table 18. Pharmaceutical Contract Manufacturing and Contract Market Trends
Table 19. Pharmaceutical Contract Manufacturing and Contract Market Drivers
Table 20. Pharmaceutical Contract Manufacturing and Contract Market Challenges
Table 21. Pharmaceutical Contract Manufacturing and Contract Market Restraints
Table 22. Global Top Pharmaceutical Contract Manufacturing and Contract Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Pharmaceutical Contract Manufacturing and Contract Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Pharmaceutical Contract Manufacturing and Contract, Headquarters and Area Served
Table 26. Global Pharmaceutical Contract Manufacturing and Contract Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pharmaceutical Contract Manufacturing and Contract by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Country (2024-2029) & (US$ Million)
Table 45. Catalent Company Detail
Table 46. Catalent Business Overview
Table 47. Catalent Pharmaceutical Contract Manufacturing and Contract Product
Table 48. Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 49. Catalent Recent Development
Table 50. Thermo Fisher Scientific Company Detail
Table 51. Thermo Fisher Scientific Business Overview
Table 52. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product
Table 53. Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 54. Thermo Fisher Scientific Recent Development
Table 55. Lonza Company Detail
Table 56. Lonza Business Overview
Table 57. Lonza Pharmaceutical Contract Manufacturing and Contract Product
Table 58. Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 59. Lonza Recent Development
Table 60. Boehringer Ingelheim Company Detail
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product
Table 63. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 64. Boehringer Ingelheim Recent Development
Table 65. Fareva Company Detail
Table 66. Fareva Business Overview
Table 67. Fareva Pharmaceutical Contract Manufacturing and Contract Product
Table 68. Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 69. Fareva Recent Development
Table 70. Recipharm Company Detail
Table 71. Recipharm Business Overview
Table 72. Recipharm Pharmaceutical Contract Manufacturing and Contract Product
Table 73. Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 74. Recipharm Recent Development
Table 75. Aenova Company Detail
Table 76. Aenova Business Overview
Table 77. Aenova Pharmaceutical Contract Manufacturing and Contract Product
Table 78. Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 79. Aenova Recent Development
Table 80. AbbVie Company Detail
Table 81. AbbVie Business Overview
Table 82. AbbVie Pharmaceutical Contract Manufacturing and Contract Product
Table 83. AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 84. AbbVie Recent Development
Table 85. Baxter Company Detail
Table 86. Baxter Business Overview
Table 87. Baxter Pharmaceutical Contract Manufacturing and Contract Product
Table 88. Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 89. Baxter Recent Development
Table 90. Nipro Corp Company Detail
Table 91. Nipro Corp Business Overview
Table 92. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product
Table 93. Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 94. Nipro Corp Recent Development
Table 95. Sopharma Company Detail
Table 96. Sopharma Business Overview
Table 97. Sopharma Pharmaceutical Contract Manufacturing and ContractProduct
Table 98. Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 99. Sopharma Recent Development
Table 100. Famar Company Detail
Table 101. Famar Business Overview
Table 102. Famar Pharmaceutical Contract Manufacturing and ContractProduct
Table 103. Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 104. Famar Recent Development
Table 105. Vetter Company Detail
Table 106. Vetter Business Overview
Table 107. Vetter Pharmaceutical Contract Manufacturing and ContractProduct
Table 108. Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 109. Vetter Recent Development
Table 110. Shandong Xinhua Company Detail
Table 111. Shandong Xinhua Business Overview
Table 112. Shandong Xinhua Pharmaceutical Contract Manufacturing and ContractProduct
Table 113. Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 114. Shandong Xinhua Recent Development
Table 115. Piramal Company Detail
Table 116. Piramal Business Overview
Table 117. Piramal Pharmaceutical Contract Manufacturing and ContractProduct
Table 118. Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 119. Piramal Recent Development
Table 120. Mylan Company Detail
Table 121. Mylan Business Overview
Table 122. Mylan Pharmaceutical Contract Manufacturing and ContractProduct
Table 123. Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 124. Mylan Recent Development
Table 125. Dr. Reddy’s Company Detail
Table 126. Dr. Reddy’s Business Overview
Table 127. Dr. Reddy’s Pharmaceutical Contract Manufacturing and ContractProduct
Table 128. Dr. Reddy’s Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 129. Dr. Reddy’s Recent Development
Table 130. Zhejiang Hisun Company Detail
Table 131. Zhejiang Hisun Business Overview
Table 132. Zhejiang Hisun Pharmaceutical Contract Manufacturing and ContractProduct
Table 133. Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 134. Zhejiang Hisun Recent Development
Table 135. Zhejiang Huahai Company Detail
Table 136. Zhejiang Huahai Business Overview
Table 137. Zhejiang Huahai Pharmaceutical Contract Manufacturing and ContractProduct
Table 138. Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 139. Zhejiang Huahai Recent Development
Table 140. Jubilant Company Detail
Table 141. Jubilant Business Overview
Table 142. Jubilant Pharmaceutical Contract Manufacturing and ContractProduct
Table 143. Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2017-2022) & (US$ Million)
Table 144. Jubilant Recent Development
Table 145. Catalent Company Information
Table 146. Catalent Business Overview
Table 147. Catalent Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 148. Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 149. Catalent Recent Development
Table 150. Thermo Fisher Scientific Company Information
Table 151. Thermo Fisher Scientific Business Overview
Table 152. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 153. Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 154. Thermo Fisher Scientific Recent Development
Table 155. Lonza Company Information
Table 156. Lonza Business Overview
Table 157. Lonza Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 158. Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 159. Lonza Recent Development
Table 160. Boehringer Ingelheim Company Information
Table 161. Boehringer Ingelheim Business Overview
Table 162. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 163. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 164. Boehringer Ingelheim Recent Development
Table 165. Fareva Company Information
Table 166. Fareva Business Overview
Table 167. Fareva Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 168. Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 169. Fareva Recent Development
Table 170. Recipharm Company Information
Table 171. Recipharm Business Overview
Table 172. Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 173. Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 174. Recipharm Recent Development
Table 175. Aenova Company Information
Table 176. Aenova Business Overview
Table 177. Aenova Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 178. Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 179. Aenova Recent Development
Table 180. AbbVie Company Information
Table 181. AbbVie Business Overview
Table 182. AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 183. AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 184. AbbVie Recent Development
Table 185. Baxter Company Information
Table 186. Baxter Business Overview
Table 187. Baxter Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 188. Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 189. Baxter Recent Development
Table 190. Nipro Corp Company Information
Table 191. Nipro Corp Business Overview
Table 192. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 193. Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 194. Nipro Corp Recent Development
Table 195. Sopharma Company Information
Table 196. Sopharma Business Overview
Table 197. Sopharma Pharmaceutical Contract Manufacturing and ContractRevenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 198. Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 199. Sopharma Recent Development
Table 200. Famar Company Information
Table 201. Famar Business Overview
Table 202. Famar Pharmaceutical Contract Manufacturing and ContractRevenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 203. Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 204. Famar Recent Development
Table 205. Vetter Company Information
Table 206. Vetter Business Overview
Table 207. Vetter Pharmaceutical Contract Manufacturing and ContractRevenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 208. Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 209. Vetter Recent Development
Table 210. Shandong Xinhua Company Information
Table 211. Shandong Xinhua Business Overview
Table 212. Shandong Xinhua Pharmaceutical Contract Manufacturing and ContractRevenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 213. Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 214. Shandong Xinhua Recent Development
Table 215. Piramal Company Information
Table 216. Piramal Business Overview
Table 217. Piramal Pharmaceutical Contract Manufacturing and ContractRevenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million)
Table 218. Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2018-2023) & (US$ Million) Portfolio
Table 219. Piramal Recent Development
Table 220. Mylan Company Information

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings